Alto Neuroscience Inc. (ANRO)
NYSE
36.28
+0.03 (+0.10%)
Closed
Aug 25, 2026
Day's Range
35.7037.16
52 wk Range
3.4137.16
Financial Statements - ANRO - Alto Neuroscience Inc.
Revenue
0
Net Income
-63.23M▼ 2.9%
EBITDA
-59.42M▲ 0.2%
Free Cash Flow
-51.79M▼ 4.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 210K |
| Cost of Goods | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
 Operating Expense | - | - | - | - | - |
| Operating Income | -66.36M | -68.61M | -37.80M | -27.45M | -9.08M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | -1M | -297K | 525K | -369K | -107K |
| Pre Tax Income | -63.23M | -61.43M | -36.30M | -27.71M | -9.18M |
| Income Tax | - | - | - | - | - |
| Net Income | -63.23M | -61.43M | -36.30M | -27.71M | -9.18M |
| EPS Basic | -2.19 | -2.5 | -1.419586 | -2.134823 | -0.944096 |
| EPS Diluted | -2.19 | -2.5 | -1.419586 | -2.134823 | -0.944096 |
| Basic Shares Outstanding | 28.85M | 24.60M | 25.57M | 12.98M | 9.73M |
| Diluted Shares Outstanding | 28.85M | 24.60M | 25.57M | 12.98M | 9.73M |
| Ebit | -60.76M | -60.05M | -34.93M | -27.71M | -9.08M |
| Ebitda | -59.42M | -59.55M | -35.08M | -26.99M | -8.83M |
| Net Income Continuous Operations | -63.23M | -61.43M | -36.30M | -27.71M | -9.18M |
| Minority Interests | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
